CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...